We suspected that when comparing sarcoma signatures between protocols for ES, the elevated expression of the EWS-FLI1 gene set in the Nuclei protocol may be due to the gene length-associated bias in snRNA-seq (Fig. 5). The gene discussed is FLI1; the disease is sarcoma.